BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31141816)

  • 21. Malabsorption syndrome and leukotriene inhibitor.
    Selva Kumar C; Das RR; Balakrishnan CD; Balagurunathan K; Chaudhuri K
    J Trop Pediatr; 2011 Apr; 57(2):135-7. PubMed ID: 20571153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic.
    Lee J; Dierkhising R; Wu TT; Alexander J; Weiler C
    Dig Dis Sci; 2011 Nov; 56(11):3254-61. PubMed ID: 21655949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group.
    Bar-Meir S; Chowers Y; Lavy A; Abramovitch D; Sternberg A; Leichtmann G; Reshef R; Odes S; Moshkovitz M; Bruck R; Eliakim R; Maoz E; Mittmann U
    Gastroenterology; 1998 Oct; 115(4):835-40. PubMed ID: 9753485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophilic gastroenteritis: An unusual presentation of a rare disease.
    Sylva D; Tamayo L; Mosquera-Klinger G; Carvajal JJ; Pérez JC
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):116-118. PubMed ID: 29555104
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis.
    Lucendo AJ; Serrano-Montalbán B; Arias Á; Redondo O; Tenias JM
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):56-64. PubMed ID: 25699593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Halo sign and araneid limb-like sign in eosinophilic enteritis.
    Huang X; Liao X; Xiao Z; Huang Z
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):954. PubMed ID: 32941835
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of montelukast on eosinophilic gastroenteritis in a mouse model.
    Wan D; Liu X; Li G
    Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):292-5. PubMed ID: 23240855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of pediatric eosinophilic gastroenteritis.
    Kobayashi S; Tsunoda T; Umetsu S; Inui A; Fujisawa T; Sogo T
    Pediatr Int; 2022 Jan; 64(1):e15322. PubMed ID: 36331233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophilic Gastroenteritis : Brief Review.
    Shih HM; Bair MJ; Chen HL; Lin IT
    Acta Gastroenterol Belg; 2016; 79(2):239-44. PubMed ID: 27382945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
    Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
    Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophilic Gastroenteritis: Using Presenting Findings to Predict Disease Course.
    Havlichek D; Choung RS; Murray JA
    Clin Transl Gastroenterol; 2021 Oct; 12(10):e00394. PubMed ID: 34620754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophil counts in upper digestive mucosa of Western European children: variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings.
    Kalach N; Huvenne H; Gosset P; Papadopoulos S; Dehecq E; Decoster A; Creusy C; Dupont C
    J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):175-82. PubMed ID: 20890222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Features and Course of Mucosal Type Eosinophilic Gastroenteritis between Korean Infants and Children.
    Choi BS; Hong SJ; Park SH; Kim HM; Choe BH
    J Korean Med Sci; 2015 Aug; 30(8):1129-35. PubMed ID: 26240491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perforated duodenal ulcer: An unusual manifestation of allergic eosinophilic gastroenteritis.
    Riggle KM; Wahbeh G; Williams EM; Riehle KJ
    World J Gastroenterol; 2015 Nov; 21(44):12709-12. PubMed ID: 26640348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic gastroenteritis treated with a multiple-food elimination diet.
    Yamada Y; Kato M; Isoda Y; Nishi A; Jinbo Y; Hayashi Y
    Allergol Int; 2014 May; 63 Suppl 1():53-6. PubMed ID: 24809376
    [No Abstract]   [Full Text] [Related]  

  • 38. High Prevalence of Eosinophilic Gastrointestinal Disease in Children With Intestinal Failure.
    Stamm DA; Hait E; Litman HJ; Mitchell PD; Duggan C
    J Pediatr Gastroenterol Nutr; 2016 Sep; 63(3):336-9. PubMed ID: 27548247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture.
    Daikh BE; Ryan CK; Schwartz RH
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):23-7. PubMed ID: 12546333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.